MARKET

ACB

ACB

Aurora Cannabis Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.610
-0.050
-3.01%
Closed 19:57 08/11 EDT
OPEN
1.690
PREV CLOSE
1.660
HIGH
1.770
LOW
1.600
VOLUME
11.87M
TURNOVER
--
52 WEEK HIGH
8.69
52 WEEK LOW
1.210
MARKET CAP
365.14M
P/E (TTM)
-0.3468
1D
5D
1M
3M
1Y
5Y
Cronos drives Canadian pot stocks lower after quarterly miss
Cronos Group (NASDAQ:CRON) led a selloff among marijuana compan...
Seekingalpha · 2d ago
'Missouri Marijuana Legalization Initiative Will Appear On November Ballot, State Announces' -Marijuana Moment Report
https://www.marijuanamoment.net/missouri-marijuana-legalization-initiative-will-appear-on-november-ballot-state-announces/
Benzinga · 2d ago
Why Is Curaleaf One Of The Best-Positioned Cannabis Multi-State Operators?
Curaleaf Holdings, Inc. (OTCQX: CURLF) posted its financial results Monday for the second quarter ended June 30, 2022.
Benzinga · 2d ago
Canopy Growth leads cannabis rally as Senator backs compromise legislation
Cannabis companies in both the U.S. and Canada have traded sharply higher on Monday in a move attributed to the recent remarks made by Sen. Cory Booker on marijuana reforms. Today's cannabis rally comes hours after the Senate Democrats pass...
Seekingalpha · 3d ago
Despite Canopy Growth quarterly results, Canadian cannabis names not trading much lower
Even though Canopy Growth Corp. (NASDAQ:CGC) reported fi...
Seekingalpha · 6d ago
Canopy gains 12% to lead Canadian cannabis rally as former Aphria legal chief joins
Canopy Growth (NASDAQ:CGC) has spearheaded a surge in th...
Seekingalpha · 08/02 15:34
Audacious FY22 Revenue Grows Staggering 1200% YoY, What's The Secret?
Australis Capital Inc. (OTCQB: AUSAF) (CSE:AUSA) released its unaudited results for its fiscal year ended March 31, 2022, revealing revenue increased by over 1,200% to nearly CA$9.5 million ($7.38 million), driven predominantly by a full year of ALPS reven...
Benzinga · 08/02 14:27
Volatility Of Cannabis Stocks: Schumer's Bill Was A 'Hail Mary', But Industry Has Other Catalysts – Experts Explain
This was a very challenging year for pot stocks. Year-to-date, AdvisorShares Pure US Cannabis ETF (ARCA:MSOS) dropped 54.01%, AdvisorShares Pure Cannabis ETF (ARCA:YOLO) declined 57.46%, compared to SPDR S&P 500 (ARCA:SPY) which lost 13.61%. 
Benzinga · 08/01 16:03
More
No Data
Learn about the latest financial forecast of ACB. Analyze the recent business situations of Aurora Cannabis Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 10 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

0.00%Strong Buy
0.00%Buy
80.00%Hold
10.00%Under-perform
10.00%Sell
Analyst Price Target
The average ACB stock price target is 5.13 with a high estimate of 7.04 and a low estimate of 3.218.
High7.04
Average5.13
Low3.218
Current 1.610
EPS
Actual
Estimate
-3.02-2.27-1.51-0.76
Q4 2021
Q1 2022
Q2 2022
Q3 2022
Q4 2022
Institutional Holdings
Institutions: 402
Institutional Holdings: 38.26M
% Owned: 16.87%
Shares Outstanding: 226.80M
TypeInstitutionsShares
Increased
66
9.18M
New
31
821.23K
Decreased
38
4.86M
Sold Out
50
1.87M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
-1.17%
Pharmaceuticals & Medical Research
-1.16%
Key Executives
Non-Executive Chairman/Independent Director
Ronald Funk
Chief Executive Officer/Director
Miguel Martin
Chief Financial Officer
Glen Ibbott
Executive Vice President
Andre Jerome
Executive Vice President
Carey Squires
Secretary
Jillian Swainson
Director
Michael Singer
Independent Director
Margaret Atkins
Independent Director
Norma Beauchamp
Independent Director
Theresa Firestone
Independent Director
Lance Friedmann
Independent Director
Chitwant Kohli
Independent Director
Adam Szweras
No Data
No Data
About ACB
Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution and sale of cannabis and cannabis related products in Canada and internationally. The Company's portfolio of brands includes Aurora, Aurora Drift, San Rafael '71, Daily Special, MedReleaf, CanniMed, Whistler, Reliva and KG7 CBD. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia; and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets. It produces approximately 150,000 kilograms (kg) of cannabis biomass annually. Its subsidiaries include 1769474 Alberta Ltd., 2105657 Alberta Inc., Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, Aurora Nordic Cannabis A/S, and Reliva, LLC, among others.

Webull offers kinds of Aurora Cannabis Inc stock information, including NASDAQ:ACB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ACB stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ACB stock methods without spending real money on the virtual paper trading platform.